Background
==========

RNA interference (RNAi) is the process through which a double-stranded RNA (dsRNA) induces gene expression silencing, by either degradation of sequence-specific complementary mRNA or repression of translation \[[@B1]\]. Nowadays, RNAi has become an effective tool to inhibit gene expression, serving as a potential therapeutic strategy in viral diseases, drug target discovery and cancer therapy \[[@B2]\]. The key inhibition mechanism of RNAi is triggered by introducing a short interfering double-stranded RNA (siRNA,19\~ 27 bp) into the cytoplasm, where the guide strand of siRNA (usually antisense strand) is incorporated into the RNA-induced silencing complex (RISC) that binds to its target mRNA and the expression of the target gene is blocked. How to design siRNAs with high efficacy and high specificity for their target genes is one of the critical research issues \[[@B3]-[@B7]\].

So far, considerable progress has been made in studying the silencing capacity of siRNAs (the siRNA binding efficacy). Some fundamental empirical guidelines for designing efficient siRNA molecules have been presented \[[@B8],[@B9]\]. Further investigations include the study of the RNAi mechanism itself as well as characteristics of siRNAs with either high or low silencing capacity \[[@B10]-[@B16]\]. In total, these studies have led to several advanced algorithms and tools that allow the selection of potent siRNAs or the prediction of the efficacy of siRNA for gene silencing \[[@B13],[@B17]-[@B26]\].

Computational models for siRNA efficacy prediction are often constructed in a training phase. The training data consist of a collection siRNA sequences and related inhibiting efficacy vis-a-vis their target genes. In the testing phase, trained models are applied to new instances, when potential characteristics related to siRNA efficacy are extracted from siRNA sequences or target mRNA and used for the prediction of siRNAs efficacy for new targets. This procedure is generally formulated as a classification or regression model \[[@B24]\]. Although various statistical and machine learning methods have been proposed in the last few years \[[@B24],[@B27],[@B28]\], there is limited success in predicting siRNA efficacy due to the diversity of data and limited sizes of available siRNA datasets. The problem caused by the differences in the training data pose difficulties for in-silico siRNA design. Typically, the RNAi data are provided by different research groups under different platforms/protocols in different experimental scenarios. This kind of data is refereed as \"cross-platform\" to emphasize the considerable diversity in such data. We observed that usually the observations (siRNA efficacy) from multiple platforms may not have an identical conditional distribution (i.e. the same residual variance) due to: First, a variety of assays/platforms/scales exist for measurements of the siRNA efficacy, such as different cell types (Hela, fibroblasts), test methods (Western Blotting, real-time PCR) or siRNA delivery methods (vectors method, synthetic oligos method). Second, there may exist very different concentrations of siRNAs used in different experiments. Finally, large differences can be found in sub-optimal time intervals between transfection and down-regulation measurement etc \[[@B24],[@B29]\].

As we show later in the experimental part, a naive integration of the data for siRNA efficacy prediction will only result in poor performance. This data distribution diversity problem has largely been ignored in many previous studies, such as the P*ȧ*l Sætrom data \[[@B24]\], a classical dataset for siRNA efficacy prediction. This dataset has been used as a benchmark for training and testing in several computational studies for siRNA efficacy prediction, but the issue of non-identical conditional distribution has not received sufficient attention \[[@B30],[@B31]\].

Since different RNAi experiments encompass siRNAs that are partially targeted on different mRNAs, how to jointly utilize different experimental datasets becomes a critical issue for large-scale RNAi screening analysis. Solutions to this problem are expected to provide new insights into the RNAi mechanism in a large-scale view. In our study, although cross-platform siRNA datasets may have different conditional distribution of their efficacy, they are related to a common biological problem and can be viewed as different prediction tasks under the same latent variables. This observation inspires us to exploit the possible synergies between different datasets, rather than combining them directly, to learn a *multi-task predictor*jointly and simultaneously for siRNA efficacy prediction. This predictor will allow different classification tasks to enhance each other during the training process, which eventually makes the efficacy prediction better than when the datasets are naively combined, or when the datasets are used separately.

In this paper, the cross-platform model construction issue was addressed by applying a simple, yet effective linear regression model based on the multi-task learning paradigm. This model was applied on multiple datasets for siRNA efficacy prediction. Recently, \[[@B32]\] presented a multi-task learning approach to learning drug combinations for drug design. In \[[@B33]\], a multi-task classification approach is applied on multiple platforms for finding out a small number of highly significant marker genes to aid in biological studies, where the emphasis is on feature selection across platforms. In \[[@B34]\], a novel transfer learning technique is applied to address such cross-platform siRNA efficacy prediction problem where the focus is on using the auxiliary domains to help improve the regression performance of a target class. To the best of our knowledge, our work is one of the first to apply the multi-task learning model for siRNA efficacy analysis for learning regression models.

To test our multi-task regression learning framework, extensive experiments were conducted to show that multi-task learning is naturally suitable for cross-platform siRNA efficacy prediction. The biological features were ranked to derive the most important common features for siRNA design across different experiments on this model. Furthermore, our experiments also validate the observation that the siRNA efficacy depends on the properties of the targeted mRNA, instead of merely on the properties of siRNA sequence. We also conjecture that continued computational siRNA efficacy study can be benefited greatly from the multi-task learning framework by focusing on a much smaller task level, where we can take, for example, each mRNA and its binding siRNAs as a task, rather than an entire experiment as a task.

Methods
=======

Data source
-----------

Our study was performed on the siRNA efficacy dataset compiled by Shabalina et al., which contains 653 19-nt siRNAs targeted on 52 genes (no homology genes between them) from 14 cross-platform experiments \[[@B23]\]. The general description of this data source is given in Table [1](#T1){ref-type="table"}, from which we can see that different experiments actually have different output label spaces in the evaluation of siRNA efficacy. It is reported that this is a mixture set of dataset including a broad range of siRNA concentrations, which, in distribution, is substantially biased towards the high end (over 300 siRNAs tested at 100 nM concentrations) in the evaluation of siRNA efficacy. The diversity in the data explains partly why the different measurement errors are non-trivial \[[@B23]\] \[Additional file [1](#S1){ref-type="supplementary-material"}\]. In addition, another two experiments with 32 siRNAs targeting on 10 distinct mRNAs are included in our study as two independent test sets \[[@B23]\]. The siRNA efficacy in these experiments was tested at very low concentrations to show that the effectiveness of our multi-task learning paradigm for predicting the efficacy of siRNAs is independent on concentrations.

###### 

Description of the 14 cross-platform RNAi experiments as well as another 2 independent experiments performed at low siRNA concentrations.

  Experiments   \#mRNA   \#siRNA   Platform label scale (min-max)
  ------------- -------- --------- --------------------------------
  E1            2        179       4.0-127.8
                                   
  E2            2        67        22.0-118.8
                                   
  E3            1        14        2-52
                                   
  E4            10       50        1.0-115.7
                                   
  E5            2        12        18-110
                                   
  E6            4        50        5.8-124.4
                                   
  E7            3        19        20-127
                                   
  E8            21       103       16.0-100.0
                                   
  E9            1        34        1.5-93.9
                                   
  E10           1        6         32-77
                                   
  E11           2        24        5-120
                                   
  E12           2        20        11.4-76.4
                                   
  E13           1        5         0-34
                                   
  E14           3        40        14-110
                                   
  IE1           6        20        1.56-100
                                   
  IE2           4        12        1-80

\"E\" denotes \"Experiment\";\"IE\" denotes \"Independent experiment\".

In our study, the same 19 parameter values were adopted for siRNA efficacy prediction as presented by Shabalina et al. \[[@B23]\] (see Table [2](#T2){ref-type="table"}), since these parameters have covered most of the reported features that are significantly correlated with siRNA efficacy so far, such as nucleotide content of G, nucleotide content of U and position-dependent nucleotide etc. Under our multi-task learning paradigm, a quantitative evaluation of these 19 features will be provided to reveal the relevance of these 19 features to siRNA design, as shown in the next section.

###### 

Feature weights for siRNA design derived from multi-task learning

  **No**.   Feature                                                                                             Weight
  --------- --------------------------------------------------------------------------------------------------- --------
  1         position-dependent nucleotide consensus: sum                                                        0.1954
  2         Δ G difference between positions 1 and 18                                                           0.0987
  3         Δ G of sense-antisense siRNA duplexes                                                               0.0774
  4         position-dependent nucleotide consensus: preferred                                                  0.0733
  5         preferred dinucleotide content index                                                                0.0726
  6         local target mRNA stabilities (Δ G)                                                                 0.0651
  7         position-dependent nucleotide consensus: avoided                                                    0.0640
  8         nucleotide content: U                                                                               0.0603
  9         stability (Δ G) of dimers of siRNAs antisense strands                                               0.0537
  10        stability profile for each two neighboring base pairs in the siRNA sense-antisense in position 1    0.0384
  11        siRNA antisense strand intra-molecular structure stability (Δ G)                                    0.0327
  12        avoid dinucleotide content index                                                                    0.0324
  13        stability profile for each two neighboring base pairs in the siRNA sense-antisense in position 13   0.0298
  14        stability profile for each two neighboring base pairs in the siRNA sense-antisense in position 18   0.0279
  15        nucleotide content: G                                                                               0.0267
  16        stability profile for each two neighboring base pairs in the siRNA sense-antisense in position 2    0.0222
  17        stability profile for each two neighboring base pairs in the siRNA sense-antisense in position 6    0.0159
  18        stability profile for each two neighboring base pairs in the siRNA sense-antisense in position 14   0.0138
  19        frequency of potential targets for siRNA                                                            0.0000

We should explain the reasons for why this particular data source is chosen: First, the data source contains nearly all the RNAi experiments with numerical siRNA efficacy values reported in recent studies, thus proven to be a complete dataset for training regression models for siRNA efficacy prediction. Second, the data source is a mixture dataset with cross-platform experiments stated in P*ȧ*l Sæ trom dataset, a dataset misused by several computational siRNA efficacy prediction models where its data diversity is not considered \[[@B30],[@B31]\]. We want to use the multi-task learning paradigm to address this cross-platform issue by comparing our test results with those of traditional studies. We noted that in the current study, we only focused on the regression model rather than the general classification models, since the siRNA efficacy values are in nature continuously valued under different experimental platforms and we don\'t want to waste any data information in using our model. Though our model is designed for regression problem, it\'s actually also suitable for the classification problem with categorical data as input. To support our argument, we applied our model in multi-task classification with the siRecords dataset \[[@B22]\], which normally standardized siRNA with consistent efficacy ratings across different platforms. The results are listed in the supplementary materials \[Additional file [1](#S1){ref-type="supplementary-material"}\], and they also indicate that our multi-task classification model is significantly better the single-task classification models.

Linear ridge regression model
-----------------------------

Given a representation of siRNAs as feature vectors, a linear ridge regression model was applied \[[@B35]\] to predict the novel siRNA efficacy from a set of siRNAs with known efficacy. Linear ridge regression is a classical statistical technique that aims to find a linear function that models the dependencies between covariances in ℝ^*d*^and response variables in ℝ, where *d*is the number of data features. The standard way to handle this problem is using the ordinary least square (OLS) method, which minimizes the squared loss:

However, due to limited training examples, the variance of the estimated *w*by OLS may be large, and thus the estimation is not reliable. An effective way to overcome this problem is to penalize the norm of *w*as in ridge regression. Instead of minimizing squared errors, ridge regression minimizes the following cost:

where λ is a fixed positive number. By introducing the regularization parameter λ, the ridge regression can reduce the estimated variance at the expense of increasing training errors. The regularization parameter λ controls the trade-off between the bias and variance of the estimate. In the linear ridge regression model, it is shown that the predicted label (i.e., *w*^*T*^*x*) of a new unlabeled example *x*is:

where *K*is the matrix of dot products of the vectors {*x*~*i*~, *i*= 1,2, \..., *n*} in the training set:

and κ is the vector of dot products of *x*and the vectors in the training set:

It should be noted that this model could be generalized to kernel ridge regression by using the kernel trick \[[@B36]\]. However, model selection is not our main focus here. Various regression models can be applied, but we choose the linear ridge regression as our regression model based on the following reasons: (1) The performance of linear ridge regression model is comparable to most of the state-of-art regression models on siRNA efficacy prediction, and it is simple enough in representation \[[@B29]\]. We applied the sophisticated support vector regression (SVR) with both linear kernel and radial basis function kernel in siRNA efficacy prediction, and we obtained nearly the same (even worse) prediction results as compared to linear ridge regression (See Results and Discussion). (2) We also want to exploit the feature importance across the platforms for better siRNA design. This goal cannot be achieved if we use a kernel regression model since it will map the input features as some non-meaningful high-dimensional representations.

In our experimental study, 5-fold cross-validation was applied to find the optimal regularization parameter that minimizes the cross-validation errors. For all the 14 experiments, 5-fold cross-validation is performed on 5 regularization parameter regions respectively, i.e. \[0.001,0.1\] with interval 0.001, \[0.01,0.1\] with interval 0.01, \[0.1,1\] with interval 0.1, \[[@B1],[@B10]\] with interval 1 and \[10,100\] with interval 10. Finally λ = 10 was obtained by evaluation of the total cross-validation errors in the 14 experiments. This parameter was kept the same throughout our study for consistent comparison.

Performance Measurement
-----------------------

In our experiments, the proposed multi-task learning and traditional single task learning were evaluated based on root mean squared error (RMSE) \[[@B35]\], which is usually used as a measurement of the prediction ability in the regression model. The residual *e*is the difference between the observed data and the fitted model, denoted as:

where *y*~*i*~is the observed siRNA efficacy and is the predicted siRNA efficacy. The root mean squared error is defined as follows:

where *n*is the number of predicted siRNA sequences. The smaller the RMSE is, the better the predict performance is.

Paired *t*-test for model comparison
------------------------------------

In our study, the paired *t*-test and *F*-test is performed to compare multi-task learning versus single-task learning in siRNA efficacy prediction \[[@B37]\]. Paired *t*-test is proven to work well by machine learning community in measuring the significance of one model outperforming another model and it is suitable for the most common data distribution assumption (say, normal distribution, instead of specific chi-squared distribution, for example) when we don\'t know the exact data distribution. To be briefly, this test is trying to determine whether the mean of a set of samples, i.e., the cross-validation estimates for the various datasets (tasks) is significantly greater than, or significantly less than the mean of another, followed by the assumptions that the observed data are from a matched subject and are drawn from a population with nearly to normal distribution.

More specifically, given two paired sets *X*~*i*~and *Y*~*i*~of *n*measured values, which could be the error rates evaluated by RMSE for each experiments under the single-task learning model and multi-task learning model in out study, the paired *t*-test determines whether this two model differ from each other in a significant way under the assumptions that the paired prediction error rate differences for each experiment are independent and identically normally distributed.

To apply the paired *t*-test, let:

Then define *t*by:

where *n-*1 is the statistic degrees of freedom. Once a *t*value is determined, a *p*-value can be found using a table of values from Student\'s *t*-distribution to determine the significance level at which two models differ.

Multi-task learning for siRNA efficacy prediction
-------------------------------------------------

### Computational framework

Multi-task learning has been developed in machine learning research to situations where multiple related learning tasks are accomplished together \[[@B38]-[@B46]\]. It has been proven to be more effective than learning each task independently when there are explicit or hidden inter-relationship among the tasks that can be exploited \[[@B47]\]. The intuition underlying the framework is that the multiple related tasks can benefit each other by sharing the data and features across the tasks, which can often boost the learning performance of each single task. Such an advantage is especially evident when the number of labeled data in each task is limited, such that training on each single task with insufficient labeled data may not work well. Recently, researchers have begun to resort to the multi-task learning model to solve biological problems, such as medical diagnosis, tumor classification and drug screening \[[@B48]-[@B50]\]. However, applications of multitask learning in bioinformatics have just begun.

In this study, a comprehensive computational framework for cross-platform RNAi experiment analysis is presented. The workfellow of the framework is shown in Figure [1](#F1){ref-type="fig"}. Extensive experimental tests were conducted to thoroughly examine the performance of the multi-task learning framework.

![**Computational framework in our study**.](1471-2105-11-181-1){#F1}

### Algorithm

In this section, we demonstrate how to formulate the cross-platform siRNA efficacy prediction problem as a multi-task learning problem. A critical issue is to learn a set of sparse (regression) functions across the tasks. In particular, *l*1-norm regularization is used to control the number of learned features common for all the tasks, and the whole multi-task learning problem is equivalent to a convex optimization problem \[[@B47]\]. Consequently, the problem is solved iteratively until convergence, by alternately performing an unsupervised step and a supervised step. In the unsupervised step, the common representations shared by the tasks are learned and then in the supervised step, these representations are used to learn the regression functions for each each task. Detailed algorithm derivations can be found in supplementary file \[Additional file [1](#S1){ref-type="supplementary-material"}\]. A Matlab script package for such multi-task learning in siRNA efficacy prediction is provided, which is accessible freely on our website.

### Feature selection across tasks

In this section, we show that the proposed multi-task learning provides us an efficient way to evaluate the feature importance in siRNA design across various platforms. Based on the parameter *W*that are derived from Equation (11), the optimal solution for matrix *D*is obtained, which can be used for feature selection. In our case, *D*is a diagonal matrix with *D*= *diag*\[λ~1~, \..., λ~*d*~\], since *U*is defined as an identity matrix. Specifically, we have

If λ~*i*~≠ 0, the *i*^*th*^feature is the common feature; otherwise, the *i*^*th*^feature is not useful in regression learning across the different tasks, since its regression weights are zeros for all the tasks. The value of λ~*i*~indicates the weight of the corresponding feature, which gives us a quantitative way to evaluate the importance of various features for siRNA design.

Results and Discussion
======================

In this section, a number of experiments on multi-task learning for cross-platform siRNA efficacy prediction are performed. The siRNA efficacy prediction problem is formulated as a linear ridge regression model and the parameters of this model are tuned with a 5-fold cross-validation process. The root mean square error (RMSE) is adopted as the performance evaluation for different test results. To verify the statistical significance of our model over the baseline algorithms, the paired *t*-test on the experimental results is also conducted \[[@B37]\].

Multi-task learning for cross-platform siRNA efficacy prediction
----------------------------------------------------------------

### STUDY 1: Single task learning

In this study, linear ridge regression was we first compared with SVR for single task siRNA efficacy prediction. As an overview, linear ridge regression was shown to achieve the same prediction results as SVR (see Table [3](#T3){ref-type="table"}). As a result, linear ridge regression was taken as the chosen learning method in the following study. We show that the 14 cross-platform experiments that we use are indeed have different conditional distribution. We will see that simple combinational or normalization methods only provide very *limited*gain on the improvement of final siRNA efficacy prediction.

###### 

Comparison between linear ridge regression and support vector regression for single task siRNA efficacy prediction.

  Test                                    RMSE                                                        
  --------------------------------------- --------- --------- --------- --------- --------- --------- ---------
  Linear ridge regression                 23.5544   23.0751   12.8477   30.2501   27.8395   32.8025   32.9677
  SVR with linear kernel                  23.6965   22.1477   13.3903   31.9928   26.1998   32.8823   32.2824
  SVR with radial basis function kernel   29.6775   24.4753   13.5664   31.1238   37.2164   36.2681   43.4349
                                                                                                      
                                          T8        T9        T10       T11       T12       T13       T14
                                                                                                      
  Linear ridge regression                 26.5710   13.6068   13.4394   36.9945   33.6679   17.3333   28.7044
  SVR with linear kernel                  27.0521   15.2284   25.9767   34.9588   32.8858   19.9620   30.7536
  SVR with radial basis function kernel   25.6995   43.3165   25.9767   32.9811   26.6623   19.9620   25.8301

\"E\" denotes \"Experiment\". Linear ridge regression and support vector regression(with linear kernel and radial basis function kernel) are trained with 50% of the data from each experiment, respectively. *p*-value calculated by pair *t*-test on linear ridge regression and SVR with linear kernel is 0.2592. *p*-value calculated by pair *t*-test on linear ridge regression and SVR with radial basis function kernel is 0.0913.

In our first test scenario (Test 1), we randomly selected 50% of the data from each experiment(or platform) as the training data to train a linear ridge regression model, and then tested it on the remaining 50% of the data in that experiment. We ran the test 10 times and reported the average RMSE for each experiment. The result of Test 1 was compared with another test scenario (Test 2), in which the same parameters are used under normalization process. In the normalization process, we scaled all the experimental labels (siRNA efficacy values) into \[0,1\] and pooled 50% of the data from each experiment together to train a general model. Finally, we tested the model on the remaining 50% of the data for each experiment, respectively. The final RMSE was calculated based on the re-scaled predicted and ground-truth labels. Results of these two tests are given in Table [4](#T4){ref-type="table"}.

###### 

Single task learning with direct combination and label scaling for siRNA efficacy prediction.

  Test     RMSE                                                        
  -------- --------- --------- --------- --------- --------- --------- ---------
  Test 1   23.5500   23.0800   12.8500   30.2500   27.8400   32.8000   32.9700
  Test 2   24.9500   29.8900   31.2700   26.8300   32.1900   29.5200   29.2500
                                                                       
           T8        T9        T10       T11       T12       T13       T14
                                                                       
  Test 1   26.5700   13.6100   13.4400   36.9900   33.6700   17.3300   28.7000
  Test 2   27.2600   15.8700   12.3700   26.2400   30.3800   21.4700   25.9700

\"E\" denotes \"Experiment\". Test 1: Selected 50% of the data from each experiment to train a regression model, and tested the model on the remain 50% of the data of each experiment, respectively. Test 2: Scaled all the experimental labels into \[0,1\] and pooling together 50% of the data from each experiment to train a general model, and tested the model on the remain 50% of the data of each experiment, respectively. *p*-value calculated by pair *t*-test on Test 1 and Test 2 is 0.7043.

From Table [4](#T4){ref-type="table"}, we can clearly see that even if the training data labels are scaled to the same level, and the training data are pooled together to train a general model for individual task prediction, the prediction results are still not improving all the time. In fact, we observe worse results in half of the experiments under this general model. Statistical test evaluation on these two models has shown that there is no statistically significant difference between these two prediction results (*p*-value = 0.7043). It indicates that directly scaling the labels and increasing the number of training data by combining the data from cross-platform experiments only provides *limited*help in improving the prediction performance; in many cases the performance is degraded. All tests so far reveal that there exists a high-level of diversity across these 14 experiments, which motivates us to apply more sophisticated multi-task learning in this study.

### STUDY 2: Multi-task learning

In this study, we show that multi-task learning is able to improve the prediction performance as compared to single-task learning. Multi-task learning is performed on the 14 cross-platform experiments with the same setting as Test 1 (50% training data as well as 50% testing data for each experiment). Furthermore, in order to examine the impact of the size of training set on the model\'s performance, we compared single task learning with multi-task learning trained with other different percentages of data from each experiment. That is, we trained the models with 10%, 30%, 70% and 90% of the whole data, respectively. The testing results are summarized in Table [4](#T4){ref-type="table"} and Figure [2](#F2){ref-type="fig"} as Test 3.

![**Comparison between multi-task learning and single task learning for siRNA efficacy prediction**. Each model is trained with 10%, 30%, 50%, 70% and 90% of the data from each experiment, respectively. STL:Single task learning. MTL: Multi-task learning. RMSE: Root mean square error.](1471-2105-11-181-2){#F2}

From Table [5](#T5){ref-type="table"}, it can be clearly seen that multi-task learning achieves better performance as compared to single task learning under various training data percentages for nearly all the experiments. An exception is for experiment 9, in which the two models obtained almost the same level of performance. Pair *t*-test evaluation indicated that multi-task learning is significantly superior to single task learning in siRNA efficacy prediction with all different percentages of training data (*p*-values are listed in Table [5](#T5){ref-type="table"}), thanks to the joint learning strategy employed in the multi-task learning model. The prediction performance of most experiments is shown to be correlated to the size of training data, both for single task learning and for multi-task learning, as shown in Figure [2](#F2){ref-type="fig"}.

###### 

Comparison between multi-task learning and single task learning for siRNA efficacy prediction.

  Test 3   RMSE                                                                                      
  -------- --------- --------- --------- --------- --------- --------- --------- --------- --------- ---------
  E1       28.3515   24.1538   23.5544   22.8080   23.4952   27.6417   24.0150   23.5313   22.7155   23.4194
  E2       28.1353   24.7949   23.0751   21.6717   20.5756   25.4531   22.0457   21.1488   20.6969   20.5423
  E3       14.1021   12.7868   12.8477   12.8390   11.2925   12.4403   11.5239   11.2708   11.0255   10.0032
  E4       36.7345   32.4953   30.2501   28.5389   25.5934   31.6222   27.8789   27.9831   27.5373   27.2947
  E5       37.7847   31.7246   27.8395   27.2221   32.1410   37.6029   27.5771   24.0499   23.5798   24.7571
  E6       37.9884   36.6409   32.8025   31.0090   27.0574   34.9948   31.9597   30.0650   28.7117   24.6019
  E7       46.1408   40.6899   32.9677   34.0303   29.4516   45.3279   34.8915   30.3053   29.9185   27.0738
  E8       29.4008   27.4798   26.5710   24.8380   26.7436   26.5423   24.6162   24.4261   23.7297   24.9686
  E9       31.9814   15.5796   13.6068   13.8639   12.2373   35.7421   19.8070   17.2665   16.2435   13.3189
  E10      56.8917   19.3907   13.4394   12.8776   11.4408   56.8917   19.1463   12.9610   12.2792   11.2242
  E11      40.4318   37.2323   36.9945   34.1775   32.1200   38.9771   31.7360   31.0361   29.2156   28.6740
  E12      30.7272   29.4070   33.6679   35.2603   24.8004   29.4405   24.4063   24.4616   24.8690   22.1497
  E13      18.8997   18.0514   17.3333   14.1208   13.5105   18.8997   17.5524   16.4534   13.1908   10.9338
  E14      34.8579   33.0815   28.7044   25.9012   25.7859   30.0917   27.8195   25.3132   24.3546   24.6832

\"E\" denotes \"Experiment\". Test 3: Comparison between multi-task learning and single task learning for siRNA efficacy prediction, both trained with 10%, 30%, 50%, 70% and 90% of the data from each experiment, respectively. *p*-values calculated by pair *t*-test on multi-task learning and single task learning with different percentages of training data: 0.0268(10%); 0.0046(30%); 0.0093(50%); 0.0151(70%); 0.0389(90%).

### STUDY 3: Testing on independent experiments

Another two experiments \[[@B23]\] were also used as independent experiments in this study (Table [1](#T1){ref-type="table"}). These experiments were tested in a very low siRNA concentration, including 6 mRNAs with 20 binding siRNAs and 4 mRNAs with 12 binding siRNAs, respectively. Two different tests were performed: (1) Single task learning was compared with multi-task learning on these two independent experiments (Test 4), and (2) Multi-task learning was performed on the two independent experiments together with the former 14 experiments, with a total of 16 experiments (Test 5). Each test kept 50% of the data as a training set as well as 50% of the data as a testing set for each experiment. The average over 10 RMSEs was compared specifically on two independent experiments under two test scenarios. The goal of these tests is to examine the influence of newly added tasks on the existing tasks under our multi-task learning model, and these newly added tasks may be generated in very different experimental conditions. Detailed test results are summarized in Table [6](#T6){ref-type="table"}.

###### 

Tests on two independent experiments.

  Tests                                          RMSE                             
  ---------------------------------------------- ---------------------- --------- ---------
  Test 4 (50% training data)                     Single task learning   34.1116   35.8600
                                                                                  
                                                 Multi-task learning    29.7394   30.5459
                                                                                  
  Test 5 (with added tasks, 50% training data)   26.6910                26.1009   

\"E\" denotes \"Experiment\". Test 4: Comparison between single task learning and multi-task learning on the two independent experiments, both trained with 50% of the data from each experiment, respectively. Test 5: Multi-task learning on the two independent experiments together with the former 14 experiments, totally 16 experiments, trained with 50% of the data from each experiment, respectively.

We make some observations from the results in Table [6](#T6){ref-type="table"}: (1) Multi-task learning gives better performance as compared to single-task learning for the two independent experiments in the siRNA efficacy prediction, and (2) Multi-task learning with more tasks proved to be more helpful for siRNA efficacy prediction, as shown in Test 5. (3) The multi-task regression generalized well to new experimental conditions (and new mRNAs) of the two independent experiments. These conclusions indicate that multi-task learning provides an effective way to alleviate the data insufficiency problem of single task domains by exploiting the available synergy between different tasks. More tasks are expected to provide much more help from a joint learning procedure. Furthermore, with more tasks, multi-task learning can help more to improve the in-silico siRNA design targeted on new mRNAs.

### Ranking features for cross platform siRNA efficacy prediction

Using our multi-task learning model, we compute the weights for each selected feature in the siRNA efficacy prediction across 14 cross-platform experiments, by considering the learned diagonal matrix *D*calculated in Equation (11). Multi-task learning in this case is also trained with 50% of the data for each experiment and randomly performed by 10 times. The features ranked with their weights are listed in order in Table [2](#T2){ref-type="table"}. It can be seen that the position-dependent nucleotide consensus features and Δ G difference between positions 1 and 18 contribute greatly to the design of efficient siRNAs. This conclusion is consistent with the study on the siRNA design as reported in recent works \[[@B51],[@B52]\]. In addition, we can see that the feature of local target mRNA stability has a relatively high weight (0.07) in determining the siRNA efficacy, and this indicates that the properties of mRNA cannot be ignored in the design of potent siRNAs. We will further discuss this issue in the following section.

Hypothesis: shall we treat task in an \"mRNA\"-level ?
------------------------------------------------------

The impact of mRNA properties (especially the secondary structure of mRNA) on the siRNA binding efficacy has long been a controversial issue \[[@B24],[@B52]-[@B54]\]. Traditional studies suggested that it may not be critical to consider the target site\'s secondary structure in siRNA efficacy prediction. Several models have been presented based on the features merely derived from siRNA sequences to predict their efficacies \[[@B18],[@B24]\]. They show that the mRNA characteristics seem to offer little to the predictive strength of their models. On the other hand, several studies have shown that the properties of mRNA may play an important role in determining the binding efficacy of a siRNA \[[@B25],[@B55]-[@B57]\]. These reports motivate us to study the impact of mRNA properties on siRNA binding efficacy from a multi-task learning perspective.

We examine the possibility for siRNA efficacy prediction from a smaller multi-task level, i.e., we consider the task at \"mRNA\" level instead of the \"experiment\" level in the efficacy prediction. If the properties of mRNA influence siRNA efficacy, siRNAs that bind to the same mRNA should have some potential connections and thus be viewed as a task in the multi-task learning model. For example, it has been reported that sequence length of target mRNA has certain positive correlation with the activity of binding siRNAs \[[@B11]\]. We speculate that there should exist certain efficacy distribution diversity *across*siRNAs binding to different mRNAs while this efficacy distribution diversity should be weak *within*the siRNAs binding to the same mRNAs. Similar to the tests performed on multiple experiments, combining siRNAs targeted on different mRNAs *may not*benefit the final prediction results. If this is the case, it could be computationally validated that the properties of mRNA indeed have an important impact on the siRNA design.

In order to validate this hypothesis, we performed tests on our siRNA data by grouping the siRNAs binding to 55 mRNAs as 55 tasks. Among them, 20 mRNAs with their number of binding siRNAs in the experiments larger than 5 were selected, and those mRNAs with a very small number of binding siRNAs were removed as they have too few instances to be viewed as a task. Our final dataset includes 20 mRNAs/tasks with a total of 482 siRNA sequences binding to them. A Detailed description of this dataset is given in Table [7](#T7){ref-type="table"}.

###### 

Description of the RNAi dataset with viewing each mRNA and its binding siRNAs as a task.

  Tasks   \#mRNA      \#siRNA
  ------- ----------- ---------
  T1      M60857      89
                      
  T2      U47298      90
                      
  T3      J03132      38
                      
  T4      U92436      29
                      
  T5      LaminA      44
                      
  T6      M16553      8
                      
  T7      NM_031313   11
                      
  T8      NM_020548   9
                      
  T9      X75932      10
                      
  T10     NM_002046   20
                      
  T11     M26071      10
                      
  T12     U47298      34
                      
  T13     M16553      6
                      
  T14     NM_001315   8
                      
  T15     NM_000875   16
                      
  T16     M25346      8
                      
  T17     AF493916    10
                      
  T18     AK122643    14
                      
  T19     NM_144586   14
                      
  T20     M33197      12

\"T\" denotes \"Task\".

Similar studies like Test 1 - Test 3 were performed on this dataset, by viewing each mRNA and its binding siRNAs as a task. The new tests are denoted as Test 6 - Test 8 and summarized in Table [8](#T8){ref-type="table"}. Table [8](#T8){ref-type="table"} shows that when the tasks were considered in a smaller \"mRNA\"-level, direct combination and scaling data label still provide *limited*help on the improvement of the prediction performance (*p*-value calculated by pair *t*-test was 0.5862). This indicates that there exists certain efficacy distribution diversity between different tasks. As expected, multi-task learning was superior to single task learning in 17 out of 20 tasks (*p*-value calculated by pair *t*-test was 0.0033).

###### 

Comparison between multi-task learning and single task learning in a \"mRNA\" task level.

  Test     RMSE                                                                                      
  -------- --------- --------- --------- --------- --------- --------- --------- --------- --------- ---------
  Test 6   22.9156   29.7953   24.4563   20.2755   13.6265   25.5433   28.6792   28.6911   13.8089   47.9704
  Test 7   22.0309   28.8772   34.4272   22.4800   29.5645   22.3986   23.4719   42.3385   16.1072   34.2505
  Test 8   22.2569   29.4852   22.9905   19.1120   11.7851   23.5123   29.9718   28.4760   11.7036   37.8482
                                                                                                     
           T11       T12       T13       T14       T15       T16       T17       T18       T19       T20
                                                                                                     
  Test 6   43.6353   13.9306   14.4649   5.6649    35.8113   33.6464   29.6981   29.4559   30.2422   21.0494
  Test 7   35.4975   16.8432   13.0795   25.0440   26.3289   36.5158   29.9756   27.0347   26.0495   21.7607
  Test 8   41.2163   18.2205   13.6913   5.7872    27.3318   27.5945   23.6955   26.5286   24.3853   16.2990

\"T\" denotes \"Task\". Test 6: Selected 50% of the data from each experiment to train a regression model, and tested the model on the remain 50% of the data of each experiment, respectively. Test 7: Scaled all the experimental labels into \[0,1\] and pooling together 50% of the data from each experiment to train a general model, and tested the model on the remain 50% of the data of each experiment, respectively. Test 8: Multi-task learning for siRNA efficacy prediction, trained with 50% of the data from each experiment, respectively. *p*-value calculated by pair *t*-test on Test 6 and Test 7 is 0.5900. *p*-value calculated by pair *t*-test on Test 6 and Test 8 is 0.0033.

We also designed a test to further examine the data characteristics of the siRNAs *within*one single task. The motivation of this test was discussed previously: since we hypothesized that there exists certain efficacy distribution diversity *across*different mRNAs/tasks in the siRNA efficacy prediction, *little*diversity should exist *within*the task. In this test, two tasks with a large number of siRNA instances were selected as the datasets (Task 1 and Task 2 with 89 and 90 siRNAs respectively). These two datasets (denoted as D1 and D2) are randomly split into 5 sub-tasks and similarly studied as Test 1 - Test 2 are performed on them respectively. Such a study is denoted as Test 9 and summarized in Table [9](#T9){ref-type="table"}. It should be noted that for each dataset, since it is selected as a single mRNA with its binding siRNAs, there should be *little*data distribution diversity across the 5 sub-tasks. As shown in Table [9](#T9){ref-type="table"}, the data combination and label scaling really work for two datasets in the improvement of efficacy prediction at this time. This is explained by saying that all siRNAs binding to one mRNA are actually homogenous in nature. The prediction performance can thus be improved by increasing the number of homogenous training data.

###### 

Test on the efficacy prediction with siRNAs binding to single mRNA.

       Test 9                             RMSE                                    
  ---- ---------------------------------- --------- --------- --------- --------- ---------
       STL                                21.7139   31.3104   22.0464   20.5358   31.3807
                                                                                  
  D1   STL with combination and scaling   20.8203   24.7029   21.2602   18.7345   28.9061
                                                                                  
       STL                                32.3753   28.3268   27.7405   22.1219   33.1770
                                                                                  
  D2   STL with combination and scaling   26.9951   25.7676   25.0711   19.9418   32.4254

\"T\" denotes\"Task\". STL: single task learning. Test 9: Two datasets (D1 and D2) are randomly split into 5 sub-tasks and similar study as Test 1-Test 2 are performed on them respectively.

In conclusion, in siRNA efficacy prediction, there indeed exists certain efficacy distribution diversity *across*the siRNAs binding to different mRNAs, and this distribution diversity seems to be weak *within*the siRNAs binding to the same mRNAs. This result helps validate the observation that the properties of mRNA indeed have influence on potent siRNA design, since certain data heterogeneity has been detected across the siRNAs binding to different mRNAs.

Conclusions
===========

In this study, a multi-task learning paradigm for cross-platform siRNA efficacy prediction is presented. Extensive empirical tests have been conducted to demonstrate that multi-task learning provides an efficient way for the alleviation of data heterogeneity and insufficiency across multiple tasks. Our method was shown to achieve better prediction performance as compared to the traditional regression models on each individual task independently. This paradigm facilitates different tasks used to learn the hidden data patterns based on a common feature representation. In addition, our experiments validated that siRNA efficacy not only depends on the properties of siRNA, but also on the properties of its targeted mRNA.

Future research on siRNA design could be done to address the data heterogeneity issue further under the multi-task learning scheme. One approach is by taking each mRNA and its binding siRNAs as a task rather than taking each experiment as a task. Another important consideration is to address the issue on finding the major causes for such heterogeneity across different experimental conditions or mRNAs. Our multi-task learning paradigm can only reveal such heterogeneity. For experimental conditions, we wish to further find out what is important on the siRNA concentration, the knockdown assay, etc., in the siRNA design. Similarly, and more importantly, we wish to pursue the question of identifying the most important characteristics that determine the siRNA binding efficacy. Addressing these issues would help to shed new light on why certain genes seem to be easier to be knocked down by RNAi than others. We believe that a better understanding to such problems can be achieved when the amount of available data increases and more new features that influence siRNA-mediated RNA interference are identified.

Availability
============

A package of matlab scripts for cross-platform siRNA efficacy prediction under the proposed multi-task learning paradigm is presented. This package together with the datasets used in our manuscript is freely accessible at <http://lifecenter.sgst.cn/RNAi/>.

Authors\' contributions
=======================

QL carried out the design and implementation of the specific computational framework for siRNA efficacy prediction and drafted the manuscript. QX modeled the cross-platform data analysis on biological data as a general multi-task learning scheme. WZ was responsible for the multi-task learning algorithm analysis from a data mining perspective. HX, ZC and QY guided the machine learning study and coordinated the required data analysis. All authors read and approved the final manuscript.

Appendix - Experimental setting for tests performed in our study
================================================================

*Test 1*: For 14 cross-platform experiments as 14 individual tasks, selected 50% of the data from each experiment to train a regression model, and tested the model on the remain 50% of the data of each experiment, respectively.

*Test 2*: For 14 cross-platform experiments as 14 individual tasks, scaled all the experimental labels into \[0,1\] and pooling together 50% of the data from each experiment to train a general model, and tested the model on the remain 50% of the data of each experiment, respectively.

*Test 3*: For 14 cross-platform experiments as 14 individual tasks, perform comparison between multi-task learning and single task learning for siRNA efficacy prediction, both trained with 10%, 30%, 50%, 70% and 90% of the data from each experiment, respectively.

*Test 4*: For 2 independent experiments, perform comparison between single task learning and multi-task learning on them, both trained with 50% of the data from each experiment, respectively.

*Test 5*: Multi-task learning on the two independent experiments together with the former 14 experiments, totally 16 experiments, trained with 50% of the data from each experiment, respectively.

*Test 6*: For the 20 tasks in a \"mRNA\" level, selected 50% of the data from each experiment to train a regression model, and tested the model on the remain 50% of the data of each experiment, respectively.

*Test 7*: For the 20 tasks in a \"mRNA\" level, scaled all the experimental labels into \[0,1\] and pooling together 50% of the data from each experiment to train a general model, and tested the model on the remain 50% of the data of each experiment, respectively.

*Test 8*: For the 20 tasks in a \"mRNA\" level, perform multi-task learning for siRNA efficacy prediction, trained with 50% of the data from each experiment, respectively.

*Test 9*: Two datasets (D1 and D2) with siRNAs binding to single mRNA are randomly split into 5 sub-tasks and similar study as Test 1-Test 2 are performed on them respectively.
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======================

###### Additional file 1

**Supplementary materials for the manuscript**. This file contains detailed explanation of multi-task learning algorithm, together with the description of the data used in our study

###### 

Click here for file
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